WillisH.NavarroMD(He/Him)
Hematology • Minneapolis, MNHematologic Oncology
VP, Head of Clinical Development and Pharmacovigilance Aadi Bioscience, Inc.
Dr. Navarro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Fulton Ave SE
2nd Floor
Minneapolis, MN 55455Phone+1 612-676-4200
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1995 - 1998
Yale-New Haven Medical CenterResidency, Internal Medicine, 1990 - 1993- University of California San Francisco School of MedicineClass of 1990
Certifications & Licensure
AZ State Medical License 2023 - 2027
CA State Medical License 1995 - 2026
MN State Medical License 2019 - 2025- American Board of Internal Medicine Hematology
Clinical Trials
- Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer Start of enrollment: 1999 Jan 01
- Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab Start of enrollment: 2017 Dec 29
- Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy Start of enrollment: 2017 Dec 29
Publications & Presentations
PubMed
- 94 citationsAcute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.Michael A. Pulsipher, Pintip Chitphakdithai, Brent R. Logan, Bronwen E. Shaw, John R. Wingard
Blood. 2013-01-03 - 28 citationsUnrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee.Robert N Lown, J Philippe, Willis H. Navarro, S M van Walraven, L Philips-Johnson
Bone Marrow Transplantation. 2014-04-07 - 49 citationsAutologous stem cell transplantation for acute myeloid leukemia in first remission.Charles A. Linker, Curt A. Ries, Lloyd E. Damon, Peter H. Sayre, Willis H. Navarro
Biology of Blood and Marrow Transplantation. 2000-01-01
Abstracts/Posters
- Long-Term Outcomes of Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) Following Solid Organ (SOT) or Allogeneic Hematop...Willis Navarro, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803...Willis H. Navarro, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
